Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON53287Completed
Open-label trial of JWH018 (2 arms), sponsored by Maastricht University. Primary endpoints: Drug-induced change in glutamate neurotransmission, Drug-induced change in GABA neurotransmission and 2 more. Started Dec 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON53287.